We determined the influence of 2‐weeks quercetin supplementation (1000 mg/day) compared to placebo on exercise performance and markers of skeletal muscle mitochondrial biogenesis in 26 untrained, physically inactive, young adult males. Utilizing a randomized, crossover design with a 2‐week washout period, subjects provided blood and muscle biopsy samples pre‐ and post‐supplementation periods, and were given 12‐minute time trials on 15% graded treadmills following 60‐min moderate exercise pre‐loads at 60% VO2max. Plasma quercetin levels rose significantly during the two‐week quercetin compared to placebo supplementation period. During the 12‐minute trial (15% treadmill grade, self‐selected speed), the net change in distance achieved was significantly greater with quercetin compared to placebo (29.5±11.5 vs. ‐11.9±16.0 m, respectively, P=0.038). Skeletal muscle mRNA expression tended to increase during supplementation with quercetin compared to placebo for SIRT‐1 (P‐value=0.152), PGC‐1α (P=0.192), cytochrome c oxidase (P=0.081), and citrate synthase (P=0.166). In summary, 1000 mg/d quercetin supplementation for 2 weeks by untrained males was associated with an improvement in 12‐minute treadmill time trial performance and 16% to 25% increases above placebo levels for mRNA expression for four genes related to mitochondrial biogenesis.Supported by a Grant from Quercegen Pharma
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.